9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings : Pregabalin use and misuse in Australia

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pregabalin is a gamma-aminobutyric acid (GABA) analogue, used to treat neuropathic pain and epilepsy. Pregabalin was registered in Australia in 2005, and subsidized publically in 2013. We aimed to describe Australian patterns of pregabalin use and intentional poisoning, and identify people potentially at high risk of misuse.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Abuse and Misuse of Pregabalin and Gabapentin

          Gabapentinoid (pregabalin and gabapentin) abuse is increasingly being reported.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers

            Background The Pharmaceutical Benefits Scheme (PBS) is Australia’s national drug subsidy program. This paper provides a practical guide to researchers using PBS data to examine prescribed medicine use. Findings Excerpts of the PBS data collection are available in a variety of formats. We describe the core components of four publicly available extracts (the Australian Statistics on Medicines, PBS statistics online, section 85 extract, under co-payment extract). We also detail common analytical challenges and key issues regarding the interpretation of utilisation using the PBS collection and its various extracts. Conclusions Research using routinely collected data is increasing internationally. PBS data are a valuable resource for Australian pharmacoepidemiological and pharmaceutical policy research. A detailed knowledge of the PBS, the nuances of data capture, and the extracts available for research purposes are necessary to ensure robust methodology, interpretation, and translation of study findings into policy and practice.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?

                Bookmark

                Author and article information

                Journal
                Addiction
                Addiction
                Wiley
                09652140
                September 05 2018
                Affiliations
                [1 ]New South Wales Poisons Information Centre; The Children's Hospital at Westmead; Westmead NSW Australia
                [2 ]Clinical Pharmacology and Toxicology Research Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School; University of Sydney; NSW Australia
                [3 ]Centre for Big Data Research in Health; University of New South Wales; Sydney Australia
                [4 ]Clinical Toxicology Research Group, Faculty of Health and Medicine; University of Newcastle; Australia
                Article
                10.1111/add.14412
                30098227
                9ed3a1fd-3bd4-406a-afb8-effde49c82db
                © 2018

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor


                Comments

                Comment on this article